Financial toxicity of cancer treatment in India: towards closing the cancer care gap.

ABSTRACT:

Background

The rising economic burden of cancer on patients is an important determinant of access to treatment initiation and adherence in India. Several publicly financed health insurance (PFHI) schemes have been launched in India, with treatment for cancer as an explicit inclusion in the health benefit packages (HBPs). Although, financial toxicity is widely acknowledged to be a potential consequence of costly cancer treatment, little is known about its prevalence and determinants among the Indian population. There is a need to determine the optimal strategy for clinicians and cancer care centers to address the issue of high costs of care in order to minimize the financial toxicity, promote access to high value care and reduce health disparities.

Methods

A total of 12,148 c

SUBMITTER: Prinja S 

PROVIDER: S-EPMC10316647 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature